Annual Retained Earnings
-$46.42 M
-$18.55 M-66.54%
01 December 2023
Summary:
TransCode Therapeutics annual retained earnings is currently -$46.42 million, with the most recent change of -$18.55 million (-66.54%) on 01 December 2023. During the last 3 years, it has fallen by -$42.95 million (-1240.78%). RNAZ annual retained earnings is now -4051.73% below its all-time high of -$1.12 million, reached on 31 December 2019.RNAZ Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$57.26 M
-$2.32 M-4.23%
01 September 2024
Summary:
TransCode Therapeutics quarterly retained earnings is currently -$57.26 million, with the most recent change of -$2.32 million (-4.23%) on 01 September 2024. Over the past year, it has dropped by -$10.84 million (-23.35%). RNAZ quarterly retained earnings is now -1553.87% below its all-time high of -$3.46 million, reached on 01 December 2020.RNAZ Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNAZ Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -23.4% |
| 3 y3 years | -1240.8% | -662.8% |
| 5 y5 years | - | - |
RNAZ Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -1240.8% | at low | -662.8% | at low |
| 5 y | 5 years | -4051.7% | at low | -1553.9% | at low |
| alltime | all time | -4051.7% | at low | -1553.9% | at low |
TransCode Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$57.26 M(+4.2%) |
| June 2024 | - | -$54.93 M(+10.4%) |
| Mar 2024 | - | -$49.74 M(+7.2%) |
| Dec 2023 | -$46.42 M(+66.5%) | -$46.42 M(+9.7%) |
| Sept 2023 | - | -$42.33 M(+14.3%) |
| June 2023 | - | -$37.03 M(+13.3%) |
| Mar 2023 | - | -$32.69 M(+17.3%) |
| Dec 2022 | -$27.87 M | -$27.87 M(+22.6%) |
| Sept 2022 | - | -$22.74 M(+23.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | -$18.45 M(+33.9%) |
| Mar 2022 | - | -$13.78 M(+33.7%) |
| Dec 2021 | -$10.31 M(+197.7%) | -$10.31 M(+37.3%) |
| Sept 2021 | - | -$7.51 M(+45.0%) |
| June 2021 | - | -$5.18 M(-34.9%) |
| Mar 2021 | - | -$7.95 M(+129.6%) |
| Dec 2020 | -$3.46 M(+209.7%) | - |
| Dec 2020 | - | -$3.46 M |
| Dec 2019 | -$1.12 M | - |
FAQ
- What is TransCode Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for TransCode Therapeutics?
- What is TransCode Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for TransCode Therapeutics?
- What is TransCode Therapeutics quarterly retained earnings year-on-year change?
What is TransCode Therapeutics annual retained earnings?
The current annual retained earnings of RNAZ is -$46.42 M
What is the all time high annual retained earnings for TransCode Therapeutics?
TransCode Therapeutics all-time high annual retained earnings is -$1.12 M
What is TransCode Therapeutics quarterly retained earnings?
The current quarterly retained earnings of RNAZ is -$57.26 M
What is the all time high quarterly retained earnings for TransCode Therapeutics?
TransCode Therapeutics all-time high quarterly retained earnings is -$3.46 M
What is TransCode Therapeutics quarterly retained earnings year-on-year change?
Over the past year, RNAZ quarterly retained earnings has changed by -$10.84 M (-23.35%)